miR-17-5p slows progression of hepatocellular carcinoma by downregulating TGFβR2-Reference-Cited by-同舟云学术

miR-17-5p slows progression of hepatocellular carcinoma by downregulating TGFβR2

Published:2023-04-06 Issue:10 Volume:25 Page:2960-2971
ISSN:1699-3055
Container-title:Clinical and Translational Oncology
language:en
Short-container-title:Clin Transl Oncol

Author:

Liu Hao-Tian,Luo Cheng-Piao,Jiang Meng-Jie,Deng Zhu-Jian,Teng Yu-Xian,Su Jia-Yong,Pan Li-Xin,Ma Liang,Guo Ping-Ping,Zhong Jian-Hong^ORCID

Funder

the Specific Research Project Grants of Guangxi for Research Bases and Talents

National Natural Science Foundation of China

Guangxi Undergraduate Training Program for Innovation and Entrepreneurship

the Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumors (Guangxi Medical University), and the Chinese Ministry of Education

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s12094-023-03164-y.pdf

Reference44 articles.

1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.

2. Zhong JH, Ke Y, Gong WF, Xiang BD, Ma L, Ye XP, et al. Hepatic resection associated with good survival for selected patients with intermediate and advanced-stage hepatocellular carcinoma. Ann Surg. 2014;260(2):329–40.

3. Yang JD, Hainaut P, Gores GJ, Amadou A, Plymoth A, Roberts LR. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol. 2019;16(10):589–604.

4. Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7(1):6.

5. Komoll RM, Hu Q, Olarewaju O, von Döhlen L, Yuan Q, Xie Y, et al. MicroRNA-342-3p is a potent tumour suppressor in hepatocellular carcinoma. J Hepatol. 2021;74(1):122–34.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TGF-β1 overexpression in severe COVID-19 survivors and its implications for early-phase fibrotic abnormalities and long-term functional impairment;Frontiers in Immunology;2024-08-29

2. Exploring non-coding RNA mechanisms in hepatocellular carcinoma: implications for therapy and prognosis;Frontiers in Immunology;2024-05-10

3. The Role of the Transforming Growth Factor-β Signaling Pathway in Gastrointestinal Cancers;Biomolecules;2023-10-19